Transgene Biotek Ltd — Important, 13-07-2026: Company Update

Transgene Biotek has confirmed its compliance with share transfer agent processes for dematerialization and rematerialization of shares for the quarter ending June 30. The company, via its Registrar and Share Transfer Agent, reported that securities received for dematerialization were duly processed, confirmed with depositories, and listed on the stock exchange. Certificates were cancelled, and the register of members updated promptly, ensuring efficient electronic share handling for investors.